Your browser doesn't support javascript.
loading
Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein.
Pan, Zeyan; Di, Shengmeng; Shi, Bizhi; Jiang, Hua; Shi, Zhimin; Liu, Ying; Wang, Yi; Luo, Hong; Yu, Min; Wu, Xiuqi; Li, Zonghai.
Afiliação
  • Pan Z; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Di S; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Shi B; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Jiang H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Shi Z; CARsgen Therapeutics, Shanghai, China.
  • Liu Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Wang Y; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Luo H; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Yu M; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Wu X; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China.
  • Li Z; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, No. 25/Ln. 2200, XieTu Road, Shanghai, 200032, China. zonghaili@shsmu.edu.cn.
Cancer Immunol Immunother ; 67(10): 1621-1634, 2018 Oct.
Article em En | MEDLINE | ID: mdl-30078052
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Receptores de Antígenos de Linfócitos T / Linfócitos T / Carcinoma Hepatocelular / Glipicanas / Receptor de Morte Celular Programada 1 Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Receptores de Antígenos de Linfócitos T / Linfócitos T / Carcinoma Hepatocelular / Glipicanas / Receptor de Morte Celular Programada 1 Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China